Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michelle Santos
Observed name:
Michelle Marques dos Santos
Institution:
Roche (Canada)
Observed institutions:
University of Toronto,
Roche (Canada)
ORCID:
0009-0001-0933-6446
Observed ORCID:
0009-0001-0933-6446
OpenAlex ID:
A5050496347
Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry
2022
·
Man-Chiu Poon
, Adrienne Lee
, et al.
·
Blood
·
4
Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry
2021
·
Man-Chiu Poon
, Adrienne Lee
, et al.
·
Blood
·
3
Enhancing Engagement to Support Shared Decision Making Within Haemophilia: Development of Materials for People With Haemophilia, Caregivers and Healthcare Professionals
2025
·
Laura Meade
, Haowei (Linda) Sun
, et al.
·
Haemophilia
·
2
PDF
Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry
2026
·
Alfonso Iorio
, Federico Germini
, et al.
·
Blood Advances
·
1
PDF
Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry
2023
·
Man-Chiu Poon
, Adrienne Lee
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
6
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type